Onyx Pharmaceuticals, Inc., an Amgen subsidiary – Multiple myeloma

Access Program Information

<p>If you are a physician, please get in touch with Idis using the contact details provided to enquire about availability in your country. Due to regulations governing access in this setting, Idis can only respond to requests from physicians. If you are a patient, please speak to your treating physician.</p>

Rare Disease: